An Act to amend the Food and Drugs Act, the Hazardous Products Act, the Radiation Emitting Devices Act, the Canadian Environmental Protection Act, 1999, the Pest Control Products Act and the Canada Consumer Product Safety Act and to make related amendments to another Act

This bill was last introduced in the 42nd Parliament, 1st Session, which ended in September 2019.

Sponsor

Status

This bill has received Royal Assent and is now law.

Summary

This is from the published bill.

This enactment enables Canada to implement the Agreement on Trade Facilitation, which was done at Geneva by members of the World Trade Organization, including Canada, on November 27, 2014, as an amendment to Annex 1A of the Marrakesh Agreement Establishing the World Trade Organization.
It amends the Food and Drugs Act, the Hazardous Products Act, the Radiation Emitting Devices Act, the Canadian Environmental Protection Act, 1999, the Pest Control Products Act and the Canada Consumer Product Safety Act, to bring them into conformity with Canada’s obligations under the Agreement on Trade Facilitation.
It also makes related amendments to another Act.

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:05 p.m.


See context

Liberal

Ken Hardie Liberal Fleetwood—Port Kells, BC

Mr. Speaker, over and above that dangerous goods that might pass through Canada, I am wondering about goods that we would perhaps not allow into Canada and would rather not see traded, such as ivory, shark fins, and those sorts of things. Has there been any thought given or provisions in this legislation to prevent those types of goods from passing through, even if they are on their way through to a third country?

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:05 p.m.


See context

Liberal

David Lametti Liberal LaSalle—Émard—Verdun, QC

Mr. Speaker, it is my understanding that those goods are prohibited, period, and they are not caught or saved in any way by this legislation.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:05 p.m.


See context

Scarborough Southwest Ontario

Liberal

Bill Blair LiberalParliamentary Secretary to the Minister of Justice and Attorney General of Canada

Mr. Speaker, I also would like to add my thanks to the Parliamentary Secretary to the Minister of International Trade for his remarks and his very cogent explanation of the benefits of the full implementation of the TFA.

We have certainly come to understand that the implementation of this trade agreement will provide an opportunity to open up new markets for Canadian products, to grow businesses, and create jobs in this country.

Can the parliamentary secretary give us some idea of how these benefits can flow to Canadian businesses and companies so we can continue to grow our economy, create new opportunities for Canadians, and improve the quality of life of all of our people?

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:05 p.m.


See context

Liberal

David Lametti Liberal LaSalle—Émard—Verdun, QC

Mr. Speaker, I will not focus my answer on large enterprises, because they have the means to familiarize themselves with trade rules and to get all the help they need through customs, customs brokers, etc. What I think this bill would really help are the small and medium-sized enterprises who perhaps do not have the means. The bill would facilitate the movement of goods and services and allow them to conceive of the possibility of trade.

Hopefully, we as a government will be able to promote the possibilities that become available under this agreement and take away the fear of trading by removing some of the stickiness involved in moving goods and services across border.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:05 p.m.


See context

Conservative

Marilyn Gladu Conservative Sarnia—Lambton, ON

Mr. Speaker, this may be a bit of a detailed question, but I am curious. When we talk about bringing things through the country, Canada has quite specific labelling requirements for WHMIS, or transportation of dangerous goods. I am wondering, for the safety of the workers who might come into contact with these goods, if those standards would be applied, or other standards.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:10 p.m.


See context

Liberal

David Lametti Liberal LaSalle—Émard—Verdun, QC

Mr. Speaker, I am afraid I do not have the answer at the tip of my tongue. We have worked with the various ministries, including the Minister of the Environment, who deal with hazardous goods. Again, they have given us assurances, but I would be happy to look into the question and get back to the hon. member.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:10 p.m.


See context

Conservative

Garnett Genuis Conservative Sherwood Park—Fort Saskatchewan, AB

Mr. Speaker, today I would like to talk about free trade in general and Bill C-13 in particular.

Our caucus is of one mind on this bill. We agree on the importance of free trade in general, and we believe that these agreements benefit Canada in many ways.

This bill ratifies the multilateral agreement on trade facilitation. The agreement on trade facilitation breaks down non-tariff trade barriers and informal barriers. This is of vital importance. If all countries ratify the agreement, it could generate an estimated $1 trillion in new economic activity.

It is a pleasure for me to rise today to speak to Bill C-13. I always have to double-check when I find myself agreeing with what members of the government are doing just to ensure I have not missed anything. However, it is a pleasure for me to speak in favour of the bill. I do not know if the government will like everything I have to say in my speech today, because I will be somewhat critical of some of the things the government is doing with respect to trade. However, when it continues with good work that was started under the previous government, it is always worth recognizing that it is not all bad.

Broadly speaking, I want to do two things in my speech today. First, I want to speak specifically to some of the technical issues around the trade facilitation agreement, Bill C-13, and trade more generally. I also want to comment on our strategic situation in terms of trade, such as where it seems the government is going and where we should be going when it comes to our approach to trade.

Let me first speak to the technical side. By way of background, Bill C-13 would implement the trade facilitation agreement. Negotiations on the trade facilitation agreement started back in 2001. The agreement was completed at the WTO ministerial conference in December 2013.

This is the first multilateral agreement since the creation of the World Trade Organization. We deal at times with bilateral trade agreements, which are trade agreements between Canada and one other country, or we deal with multilateral trade agreements that involve regional or perhaps like-minded blocs of nations. This, however, is a truly multilateral agreement that could include the full membership of the WTO if all of the nations involved choose to ratify the agreement. It is an important step forward.

This trade agreement deals with the issue of trade facilitation. We are all familiar with what a formal barrier would look like to trade, for preventing countries from trading, or a tariff barrier, which is a tax on imports that a country might impose. The trade facilitation agreement seeks to deal with non-tariff barriers, or more informal barriers to trade, its regulatory misalignments, perhaps differences in regulations or administrative rules that have the effect of being a trade barrier. Perhaps they are not intended to be trade barriers and certainly are not advertised as such, but they end up preventing international commerce. This is a major issue for many businesses. If a company is seeking to trade with another country and it has to go through a detailed process of learning completely different regulations on relabelling then it becomes much more difficult for that company to do business.

What the committee heard when it studied this issue was something we had heard before. These non-tariff barriers in particular impose an additional and a unique burden on small and medium-sized businesses. A large corporation would have the capacity, the relationships in place, to understand what different regulatory regimes are and the effects of them and would have an easier time navigating these things. I do not want to suggest there is no impact on larger businesses, which employ many Canadians and many people around the world as well, but small and medium-sized businesses often have a much harder time responding to these non-tariff barriers. We know the importance of small business. It is the primary engine of growth and job creation in our country. Therefore, with respect to the impact on small business in particular, it is important we be concerned with non-tariff as well as tariff barriers on trade.

We have some information in terms of estimates from the World Trade Organization about what the impacts of this trade facilitation would be. If all countries ratify, global merchandise exports would be up by $1 trillion, and trade costs for World Trade Organization members would go down about 14%, and 17% for least developed countries. Therefore, we see significant benefits from the trade facilitation agreement. Of course if not every country ratifies, the agreements will be less, so we hope all countries ratify. However, the benefits will still be in place even if the two-thirds threshold that is required to bring this deal into force is met but not all countries involved signed.

I have a couple of other notes on trade facilitation. It provides business with predictability. One of the issues with non-tariff barriers to trade is that even if trade is possible, if trade can occur, non-tariff barriers, or arbitrary different regulatory structures can create uncertainty, which makes it much harder for importers or exporters to manage in the context of international trade. Therefore, it smooths out and aligns these regulations, and also establishes a consistency in place, a predictability for businesses to rely on to facilitate that trade to its full potential.

I also want to identify for members of the House that the requirement is that two-thirds of World Trade Organization members sign on in order for this deal to take effect. That requirement would be 110 members of the World Trade Organization. Currently, we are at 92. Some of our major trading partners, the U.S., China, the EU, Japan, have all ratified the agreement already. Therefore, we are very close to that 110 mark. With Canada taking this important step forward, a step that began in 2001 with negotiations, in 2013 with the signing of the agreement, and now moving forward for ratification, it is a step that will pay substantial dividends for all businesses but especially for our small and medium-sized businesses.

The good news is that most of our laws already comply with the trade facilitation agreement. However, Bill C-13 completes those legislative changes that are required to facilitate the full implementation of it. In particular, it makes two amendments that accord with different provisions of the trade facilitation agreement. One of those provisions is article 10.8.1 of the trade facilitation agreement. The amendment in Bill C-13 would give Canada the authority that we need to deal with goods that are brought into Canada that are non-compliant. This gives us the ability to respond to problems that come up, and opens the door for us to implement this agreement.

The other one is from article 11.8 of the agreement, which gives Health Canada and Environment and Climate Change Canada the legislative authority to exempt certain goods from certain Canadian requirements if those goods are not destined to end up in Canada, but would transit through Canada. Therefore, if Canada is a transit point for certain goods and the requirements we have in Canada for those goods are not exactly met, perhaps from an environmental or health perspective, they can still transit through Canada, but only on the basis of regulations and exceptions made through those departments. At least there is a provision for those carve-outs to be made, but also there are protections in place to ensure that those goods do not end up in Canada.

This provides a good mechanism for complying with the requirements of the trade facilitation agreement for getting the benefits of it for our economy and for our job creators, especially for small business. Also, it does not negatively affect the health and safety of Canadians or the environment. Therefore, the legislation is good, it strikes a good balance, and it is one that I and my colleagues will support.

I want to talk as well about the importance of international trade. This is a positive step as a new international multilateral trade deal. Our support for it underlines our belief on this part of this side of the House that Canada is a trading nation, that we benefit from international trade, and further that there is solid economic science behind the idea of international trade. This is something that most economists agree has clear benefits.

It is not a commitment to trade, it is not a government agreement that governments will trade, but it opens up the freedom for individuals within different countries to freely exchange, to make mutually beneficial exchanges, with people in other countries. We know that the common effect of that is greater degrees of specialization and it allows partnerships to be forged between countries, which can lead to more efficient production, the realization of new markets, and the creation of new wealth.

Our country clearly has seen the benefit of international trade. Of course at the time when it was a Conservative government that pursued free trade with the United States, trade was opposed by both the Liberals and the NDP at that time. However, at least the Liberals have come to recognize the wisdom of that approach. Under the previous Conservative government we were very bullish in recognizing the benefits of international trade and moving forward with trade agreements.

We understood this basic economic science of trade, that giving people the freedom to make mutually beneficial exchanges was good for everyone. It would not make much sense to say that I cannot shop at certain restaurants because of what side of town I live on. Exactly the same principle applies for international trade.

There is that technical basis for international trade that we can prosper together as a global community and that we can draw on the wisdom of economics in terms of understanding those benefits.

On the other hand, there is a strategic dimension of trade. We do not just unilaterally open ourselves up to international trade, but we do proceed in a methodical way with negotiation with other countries to try and open up markets in a reciprocal way, but also to align ourselves as much as possible when it comes to human rights, protection of the environment, and labour. It is worth underlining why we do this. It is because we know trade allows us to prosper nationally and together with other countries, but trade also is an opportunity to build strategic partnerships with specific nations to deepen our friendship, to deepen the sharing of ideas and of commerce between those nations. As such, it is important that we approach trade in a way that reflects our values.

With regard to the trade facilitation agreement, it is very positive from a strategic perspective that we are able to move together as a relatively united global community on this, that this reflects a consensus of different countries. In our other trade dealings, it is important for us to move with this thought out strategic lens on the point of trade as well, and I say this with respect to the trans-Pacific partnership.

To its credit, however, the government has moved this particular issue fairly quickly through the committee. This was an issue that there was an ability to move forward in a thoughtful but time-sensitive way on it.

On the other hand, the trans-Pacific partnership has been sitting on the government's desk for a full year tomorrow, since the election. The government has not even taken a position on that issue. I and other members have spoken before about the economic benefits, we could perhaps say about the technical side in terms of the benefits of the trans-Pacific partnership, but it also has great strategic significance. This was a key part of President Obama's foreign policy in terms of aligning with other democratic nations throughout the Pacific region, nations which share our values, by and large, and establishing a trade agreement that would set the terms of trade in a way that was aligned with our values.

It is Canada, the U.S., Mexico, Japan, Australia, New Zealand, among other nations, coming together with an agreement that provides those robust protections that reflect our Canadian values. It is a mechanism, yes, for pursuing economic prosperity, but also for achieving a strategic advantage that reflects our values.

It is no secret, of course, that the kinds of values that are reflected in the trans-Pacific partnership are different from the approach taken by a country like China, which is also seeking dominance in the Asia-Pacific region with a different approach when it comes to human rights, the environment, labour rights. I would passionately say that our approach is more in line with an understanding of universal human values and an appreciation of universal human dignity. It is not a particularly western or exclusive approach. It is not an approach in terms of the human values that we emphasize as particular to one community or one culture. It is a set of values that we have that are worth using the mechanism of trade deals to strategically advance in that region.

I will just say, perhaps pre-empting a question from my friends in the NDP caucus, that they have been right to raise human rights issues in Brunei, which is part of the trans-Pacific partnership. There are human rights issues in some of the countries involved; there is no doubt about it. I think the situation in Brunei very well deserves the attention of members of the House. However, being a relatively small player in the scheme of the overall agreement, the agreement still very much reflects the values that we have here in Canada, the values that nations within our community of partners and allies of like-minded nations share together.

Yes, for economic technical reasons, but also for strategic reasons, it is important that we prioritize the trans-Pacific partnership. It is important that we move forward with that in order to set the terms of trade in the Asia-Pacific region in a way that reflects our values. Of course, we know that the government has a different approach when it comes to this strategic approach to trade. In the last year, it has not stated any kind of position on the trans-Pacific partnership, but it has talked in a very bullish way about moving forward with free trade with China on a bilateral basis.

My view is that we can be stronger in terms of our strategic interests when we work with our allies. When we do not, instead, we put ourselves in a position where we could very well be at a real disadvantage in terms of negotiations with China. It gives China an opportunity to try to set the terms of trade when it comes to human rights, when it comes to the environment, when it comes to labour rights and other kinds of issues.

We can benefit economically from trade at every level; there is no doubt about it. However, from a strategic perspective, would we not be wise to first move forward with the trans-Pacific partnership and continue to pursue trade arrangements with Europe? Hopefully, we will soon see the full ratification of the Canada-EU free trade deal, successfully negotiated as well under the previous government but continued with by the current government, to its credit. We should start by nailing down those trade deals with like-minded nations and then proceed collaboratively with those like-minded nations when we approach countries like China that do not share our fundamental values. We need to approach trade in a strategic way.

I think the trade facilitation agreement reflects our values. It is a positive step that the world is able to come together on, but we need to prioritize the advancement of our values and be strategic. That is why I really hope that at some point at least we will hear an answer from the government on TPP, and hopefully in the not-too-distant future, recognizing as well the technical benefits of trade, the economic benefits that I have spoken about, specifically for the trade facilitation agreement, but also the strategic benefits.

I am pleased to be supporting the bill. Hopefully, we will see its passage very soon and be able to move forward on some of these other trade issues that I have raised as well.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:30 p.m.


See context

Liberal

Kyle Peterson Liberal Newmarket—Aurora, ON

Mr. Speaker, I want to thank my friend opposite for his contribution today and for his support of Bill C-13, which is very much appreciated. I think we come from the same point of view where free trade and fair trade is actually great for Canada, great for Canadians, good for the economy, and good for the middle class. We certainly share that, and we appreciate the support from that side of the aisle.

I want to talk a bit about his comments on the TPP. Being part of the trade committee, and frankly, having lived TPP since I was fortunate enough to be elected here almost a year ago, it has been on the top of my priority list in my short tenure as a member of Parliament.

There are some things I want to make sure the House is aware of. We are consulting with Canadians. It is not sitting on anyone's desk. We have heard from thousands upon thousands of people, at committee, through submissions, and through live witnesses of course. The ministry has travelled across the country. The committee travelled across the country as well, so we are hearing from Canadians, and we are hearing a divergence of opinions, which should not come as any surprise to anyone who has travelled across the country.

There is a lot of support for it, absolutely. There are also some concerns and opposition to it. We are trying to balance it all in a reasonable and objective manner. I can assure the member opposite that in due course there will be a report before the House. I look forward to what I know will be a hearty and fulsome debate on that point of view.

I take to heart the member's comments about China and the trans-Pacific partnership countries, but does he think it has to be an either-or? If it is the right deal, should we be as expansive as possible with the countries that we enter into free trade deals with?

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:30 p.m.


See context

Conservative

Garnett Genuis Conservative Sherwood Park—Fort Saskatchewan, AB

Mr. Speaker, I am glad to hear the member is in favour of trade. I certainly hope he will make his voice heard by other members of his party who are a little more skeptical.

I recognize the work of the trade committee when it comes to consulting on the trans-Pacific partnership and hearing from people. Not surprisingly, as on probably almost any major policy question, there are going to be different points of view and it is worthwhile to have those conversations.

It is interesting to hear time modifiers that are non-specific. I am always somewhat suspicious when we hear things like “in due course”, because when a member says something will happen in due course, that is not actually a meaningful description of time. The government should take a position on the trans-Pacific partnership. A year should have been enough time, and if it is not enough time, it would be nice to hear from the member, or from the minister, or someone else, at what point we can expect a decision from the government. Yes, at some point, in due course, the trade committee will present a report, but in due course after that perhaps we will have to wait until we hear from the minister.

I agree with the member that when it comes to trade agreements it is not an either-or. Obviously, we are talking about the trade facilitation agreement today. I made some comments about the trans-Pacific partnership and we have the Canada-EU agreement going on, but there is a question about how we approach trade with China.

Trade with China increased under the previous government. While we were talking tough on human rights issues, trade increased. However, it is a question of how we approach China. Do we do it in a way that is in concert with our allies, that reflects values that we have established, terms of trade that have been established with the trans-Pacific partnership, or do we jump the gun and negotiate a separate deal with China, which may have implications on what our approach is to other trade deals? Of course the member knows that trade deals can have implications on each other depending on the kinds of terms signed.

I am not saying it is an either-or, but these things have to be approached in a calculated and strategic way.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:30 p.m.


See context

NDP

Tracey Ramsey NDP Essex, ON

Mr. Speaker, I thank my colleague from Sherwood Park—Fort Saskatchewan for his passion on trade. It is something I share, as vice-chair of the trade committee and critic for our party.

I found some of his comments quite interesting. I am happy he will be voting in support of Bill C-13. We did incredible work at our committee, although very fast. I commend everyone on the committee for the work we did on this file. I agree with the member, and I am glad to hear him say we need to approach trade strategically. That involves listening to a lot of different voices that, unfortunately, were not heard under the previous government. There were many people who sat before the trade committee as witnesses in the TPP discussions that, unfortunately, were not part of the conversation under the Conservative government. I am happy to see those people are represented now at the table.

I am curious about the TPP specifically. I agree that the NDP applies a human rights lens to trade, but we certainly include the cost of drugs for Canadians in that human rights lens. We know that in the trans-Pacific partnership and in CETA there will be an increased cost to Canadians. We already are one of the highest-priced countries in the OECD. Canadians cannot afford the medication that they currently need in our system.

I am curious. Earlier, the member for Sherwood Park—Fort Saskatchewan and I were discussing this issue in the House and I questioned him as to whether he had had a town hall on the trans-Pacific partnership. Therefore, is his position here on the trans-Pacific partnership and the other trade agreements that he mentioned based on the views of his constituents? Has he actually consulted with them?

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:35 p.m.


See context

Conservative

Garnett Genuis Conservative Sherwood Park—Fort Saskatchewan, AB

Mr. Speaker, I am always pleased to share the approach that I take to consultation in my own constituency.

We have regular round tables on a range of different topics and we have discussed the TPP at them. Honestly, I cannot recall if we had a general trade round table or if it was a specifically TPP-only round table, but certainly we have had discussions at some of the various round tables we have had about the trans-Pacific partnership.

We invite people who write to our office about this or other issues to participate in these round tables, which we have on a regular basis. I know that constituents who have participated in them have really appreciated the opportunity to not only discuss issues with me but with each other, and to learn perhaps from the different points of view that have been represented around the table.

To answer the member's direct question, certainly, my sense is that my constituents are strongly supportive of international trade in general and of the trans-Pacific partnership in particular. I certainly appreciate the opportunity to consult in that way.

In terms of some of the comments that the member made with respect to what happened under the previous government with the trans-Pacific partnership, it is an important point, obviously, that trade agreements are not negotiated in public. However, there is a process by which stakeholders are given the opportunity to access information, to be involved in the discussion, provided that they are not disclosing that information publicly.

I think all members in the House can understand why we cannot issue a press release every time a negotiating position shifts or changes in the midst of these complicated negotiations. I mean, if that were the approach Canada took, it just would not be practical for us to be involved in negotiating trade deals, period. However, there are stakeholders that are involved throughout the process.

In fact, when the trans-Pacific partnership deal was announced, there was a huge amount of stakeholder support, in many cases from stakeholders who had previously had significant questions about it. There were people, for instance, within the agriculture community who initially were concerned about what the implications of the trans-Pacific partnership would be, but then were very positive about it once it was actually released.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:35 p.m.


See context

Liberal

Ken Hardie Liberal Fleetwood—Port Kells, BC

Mr. Speaker, I thank members for the comments on the trade agreement. I am not a member of the committee that has been studying it, so I am coming at this as an interested outsider.

What we may observe south of the 49th is that protectionist sentiment seems to be growing quite rapidly. In fact, we have witnessed the difficulties with things like the softwood lumber agreement, and diafiltered milk is another one that lurks in the corner.

Based on this and what committee members have heard and discussed, does the hon. member think that the workup we are doing right now on trade agreements, on facilitating trade, may in fact be spinning our wheels, given that the foundation upon which we were going forward seems to be shifting with the attitude presented by both of the leading contenders for the leadership of the United States?

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:35 p.m.


See context

Conservative

Garnett Genuis Conservative Sherwood Park—Fort Saskatchewan, AB

Mr. Speaker, that is certainly an interesting question from my friend across the way. However, I will point out with respect to the trade facilitation agreement that it has already been ratified by the United States. Therefore, we are in the clear as far as this particular issue goes.

I always like to point out when this discussion comes up, when people talk about the rising protectionist sentiment in the United States, that there is no evidence that I have seen in terms of public opinion polls that there actually is rising protectionist sentiment among the general population. There seems to actually still be, among the general population, a significant level of support and appreciation for the value of open trade.

Perhaps it is better to speculate on whether it is the nature of the primary system or some other reason that seems to lead to a pull in the positions of candidates in both parties towards a little more of a skeptical position on trade. However, I am optimistic that cooler heads will prevail in the final analysis. Of course, the United States has more of a divided government system, and one in which I think many politicians as well as the public understand the value of trade.

It behooves us here in Canada to make a strong argument in favour of the open economy. What I fear the government is doing on the trans-Pacific partnerships is just waiting to see what happens in the American election. The Liberals are not actually waiting to get feedback from Canadians. They are just waiting to see what happens in the United States so that they do not find themselves too far out on the point.

I think we have an obligation, given how important this deal is, given how important the open economy is, for our—

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:40 p.m.


See context

The Assistant Deputy Speaker Anthony Rota

Order. It is my duty, pursuant to Standing Order 38, to inform the House that the questions to be raised tonight at the time of adjournment are as follows: the hon. member for Burnaby South, Status of Women; the hon. member for Trois-Rivières, the Mining Industry; the hon. member for Drummond, Official Languages.

Food and Drugs ActGovernment Orders

October 18th, 2016 / 4:40 p.m.


See context

NDP

Tracey Ramsey NDP Essex, ON

Mr. Speaker, I am pleased to speak at third reading of Bill C-13, a bill the NDP supported at second reading and at committee, because of its potential benefit to Canadian small businesses that export their goods around the world.

Bill C-13 would amend the Food and Drugs Act, the Hazardous Products Act, the Radiation Emitting Devices Act, the Canadian Environmental Protection Act, the Pest Control Products Act, and the Canada Consumer Product Safety Act. It is a largely technical bill that is required to bring Canada into compliance with the WTO trade facilitation agreement, or TFA.

The agreement's stated desire is to expedite the movement, release, and clearance of goods, including goods in transit, which is dealt with in the first section of the 24-article document. In this section there are two clauses—8.1 on rejected goods and 11.8 on goods in transit—which require action on Canada's part in order to ratify the agreement. Bill C-13 deals entirely with these two clauses.

The TFA's second section—articles 13 to 22—is entitled, “Special and Differential Treatment Provisions for Developing Country Members and Least-Developed Country Members.” The final two articles in the third section outline a committee structure and deal with final provisions.

The customs practices of developed countries like Canada are already mostly in line with the TFA. For developing countries, this is more of a challenge, which is why a lot of the agreement's provisions focuses on them.

One of the few groups in Canada to have expressed concern about the TFA is the Council of Canadians. According to officials from Global Affairs Canada, it is concerned that the agreement would only benefit large agribusiness firms and not small-scale farmers.

The Council of Canadians chair, Maude Barlow, criticized the agreement back in 2013. She said:

This was not a historic win for developing countries at the WTO. They scrape by with modest and temporary protections for food security policies that should be completely excluded from corporate trade rules....

I understand her concerns and read with concern how India had to defend its food security programs amidst the TFA negotiations.

The WTO is certainly a flawed organization. I am well aware of the many criticisms that are levelled against it.

The Standing Committee on International Trade held a very quick study of Bill C-13. I was disappointed that we did not spend any time discussing the TFA in its broader context or dig into the supposed benefits of the agreement for Canadian traders.

We heard from Global Affairs officials, who answered specific questions about Bill C-13 and the various acts it would amend.

Two groups requested to appear: CropLife Canada, and the Canadian Consumer Speciality Products Association. It was important to hear from them because Bill C-13 has significant implications for them and, specifically, for the pest control industry.

Their first concern related to clause 31 of the bill, which they felt was unnecessary.

Their second concern was about the changes to be made to the definition of a label under the Pest Control Products Act. After some back-and-forth between the groups, the department, and committee members, we agreed to an amended definition that all parties seemed satisfied with.

As I mentioned, it would have been great to delve into the potential benefits of the TFA for Canada.

According to the government, the TFA could benefit Canadian small- and medium-sized businesses by strengthening the predictability of customs and border procedures for exports to developing countries. It could increase the ability of some Canadian SMEs to access emerging markets. However, there are a lot of reasons why more small businesses do not export.

The NDP believes strongly in the importance of supporting Canadian small businesses so they can thrive, grow, and hire. Coincidentally, this is Small Business Week in Canada. It is an opportunity to recognize the valuable contributions made by small businesses to communities across Canada.

My riding of Essex is home to hundreds of small businesses. They include auto parts manufacturers, tool and die makers, construction companies, wineries, retail stores, grocery stores, restaurants, and more. These are the small and independent businesses that help sustain our local economies and create local employment.

However, small businesses face big challenges. I am committed to working with the Windsor-Essex Regional Chamber of Commerce and all groups in Essex to help our small businesses tackle these challenges head-on.

No doubt, many of the small businesses in my riding are some of the 12% of Canadian SMEs that export.

When we talk about SMEs and trade, the federal government should seize the opportunity to assist more SMEs to do business outside our borders. Only a fraction of small businesses will export their goods, and most of this trade is with the United States.

I frequently hear from businesses in Essex about problems they experience with getting goods across the border. There are still a lot of challenges when it comes to streamlining practices and providing greater predictability. Their concerns were front of mind as I studied this legislation and the TPP and other trade agreements. I am convinced that we need to do more to support Canadian traders.

As I speak about the TFA and small businesses, I am also speaking about the kind of trade that the NDP does support. As the NDP trade critic, it is my responsibility to look at trade deals with a critical lens and to consider whether they are in the best interests of Canadians, not just our businesses but for current and future generations of Canadians.

The trade minister's favourite talking point these days is about the need for a progressive trade agenda. She has spoken about changing the way trade deals are negotiated so they serve a broader good instead of just corporate greed. What does that mean?

We have seen some of the broad strokes of what progressive trade means to the minister. She has stated that “we also have to now start building into trade agreements real effective labour protections, environmental standards and ensure that that is as much a part of the trade agreement as protections for investors.” What the minister said makes me hopeful for a new way of negotiating trade.

As my friend Lana Payne recently wrote in an op-ed published in The Telegram, “The language is good, but the devil will be in the details....Saying something is progressive doesn’t make it so, but the minister has certainly put herself and her government out there”.

I have been critical of the Liberal government for having a trade agenda that seems pretty identical to that of the Conservatives. For example, many progressive groups in Canada have called for changes to CETA, but the minister has dismissed their concerns and is only focused on twisting the EU's arm into signing the deal.

Canadians are deeply concerned about ISDS and do not feel that revised systems under CETA address their more core concerns with this mechanism.

Canadians are also concerned that the government's recent joint declaration that is supposed to strengthen environmental and labour standards is nothing more than empty promises without any legal backing.

The very same things the minister claims are elements of a progressive trade policy are lacking from her so-called gold standard CETA deal.

Similarly, the TPP is not an average trade agreement. Traditionally, a trade agreement is negotiated between country A and country B, who come to an agreement about reducing trade barriers, such as lowering tariffs.

The NDP has supported some of these agreements in the past because, after careful evaluation, on balance the deals were in Canada's best interests.

We are supporting Bill C-13 today because it would facilitate the trade of goods, which can benefit Canadian small businesses that export abroad.

Trade is a rapidly changing concept in the 21st century. It is not just about the flow of goods anymore. It is about the flow of people and services. It is not just country A and country B sitting down to negotiate anymore. Instead, negotiations are largely driven by corporate interests and big business who are advocating for a set of rules that benefit their interests.

Why big business is included is no mystery. Pharmaceutical companies stand to gain from the extra two years of patented drug costs. This keeps them out of the generic market and ultimately costs Canadians more money. In my riding, like everyone in Canada, people are suffering from the costs of medication and often have to make difficult decisions about their health based on their ability to pay for medication. Even people with a benefit plan are not covered for all medications and are often capped on the amount they can claim. One such story stuck with me from campaigning last year.

In Amherstburg I met a lovely couple and their daughter on a beautiful summer day. They live in a working-class neighbourhood with well-kept homes, and theirs was no exception. We started to talk and they told me of their recent struggles with his rare form of mouth cancer, how he had just retired from a good workplace with benefits. They were prepared to enjoy their retirement to the fullest when this diagnosis hit them. He had a good benefit package that included drug costs, but only to a lifetime maximum of $75,000. That sounds like a great deal of money but when one is faced with the diagnosis and treatment plan that he was faced with, the money was already gone. Thankfully, he was responding well to treatment, but it had changed their lives and they were justifiably worried about their ability to afford medication now with no money left in their coverage.

Many of today's so-called trade agreements are about so much more than trade. For example, only six of the TPP's 30 chapters deal with trade in the traditional sense of the term. The other 24 chapters are where we find the controversial aspects of the deal, like a new court system where investors can take democratically elected governments to court if they feel unfairly treated.

Trade agreements have to carve out governments' specific rights to legislate on issues as basic as cigarettes. It is absolutely shocking to me that legislatures have to fight to protect countries' rights to regulate things like cigarettes. In the TPP, a specific carve-out had to be made. At committee, the Canadian Cancer Society warned us that the tobacco industry has a history of abuse, seeking to turn to international trade and investment agreements to overturn bona fide public health, tobacco-control measures that apply equally to domestic and foreign companies.

We are also seeing trade agreements that dictate pharmaceutical rules that largely benefit pharmaceutical companies over the citizens governments are elected to serve. The increased patents on pharmaceuticals in the last two trade deals negotiated by the Harper governments are a deeply concerning and very contentious part of those agreements. Another woman I spoke with had to move in with her son in order to afford her medication. She was so thankful that her son was able to have her there so she could afford her own treatment and not worry about the cost of living alone. She told me that she worked hard but she was not making enough to even be able to take her own medication. These stories are not unique. They repeat, door after door in all of our communities.

We had the Canadian Nurses Association present to us at committee, and Carolyn Pullen told us in no uncertain terms that Canadians are already making difficult choices by skipping doses of medication and skipping days of treatment because they cannot afford their medication, even the generic brands. This does not speak well for us as a country. How are our most vulnerable being treated in our society? This systemic problem will continue to manifest itself in poor health outcomes for us all and in an increase in poverty for those who face the high cost of medication. Canada has the second-highest drug costs in the OECD. We are the only country in the world that has a public health care system that does not include a pharmacare program.

If members are wondering why I have been talking about the cost of medication in Canada, it is because under the provisions in CETA and the TPP, the patents for brand-name pharmaceuticals in Canada would be extended. It should come as no surprise that these extensions would lead to increased costs for all of us. On the one hand, we have people who cannot afford medication and who, along with the NDP, are calling on the government for a pharmacare program in our country. On the other hand, we have a government that is signing trade agreements that would make this current situation worse.

Some might say that increasing the length of patents makes sense because it would encourage the pharmaceutical companies to undertake more research and development in Canada. This is a widely held view. However, history shows us that the opposite has happened. In the late 1980s, pharmaceutical companies came to the federal government requesting a patent extension for these exact reasons. They committed to investing in Canadian R and D to a level of 10% of sales. For many years, there was a steady rise in the percentage being spent, and we eventually peaked at 11%. Then we hit a cliff. Our R and D nosedived to its current level of 4% and has held steady at this level for many years. That promise has not been kept and we have all paid the price for it. Yet here we are with CETA and the TPP giving the pharmaceutical companies another extension, with the only argument for it being that it will result in an increase in R and D. Let us be honest about what this means.

The point I make is that trade agreements like CETA or TPP would not be so controversial if they focused only on trade. Instead, they are omnibus agreements that, frankly, do not receive the study and oversight they deserve. On the other hand, before us today is a pretty straightforward initiative that addresses how countries like Canada can deal with goods at our borders. Although this is a highly technical piece, this is the kind of trade remedy that we in the NDP can support, and we will vote in support of Bill C-13.